Upstream Bio, Inc. (UPB) is a clinical-stage biotechnology company focused on developing therapies for severe inflammatory and respiratory diseases. Its lead antibody therapy targets pathways linked to asthma and other respiratory conditions, aiming to provide safer and more effective treatments. Upstream Bio’s growth is fueled by rising global demand for innovative respiratory therapies, strategic partnerships, and a strong pipeline addressing unmet medical needs.
On the chart, a confirmation bar with rising volume shows bullish strength. The price has entered the momentum zone after moving above the .236 Fibonacci level. A trailing stop can be placed just below this Fibonacci line using the Fibonacci snap tool, helping traders secure profits while leaving room for further upside potential.
On the chart, a confirmation bar with rising volume shows bullish strength. The price has entered the momentum zone after moving above the .236 Fibonacci level. A trailing stop can be placed just below this Fibonacci line using the Fibonacci snap tool, helping traders secure profits while leaving room for further upside potential.
Traders Toolkit
link.traderspro.com/toolkit
Daily email newsletter
link.traderspro.com/dailytrade
link.traderspro.com/toolkit
Daily email newsletter
link.traderspro.com/dailytrade
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Traders Toolkit
link.traderspro.com/toolkit
Daily email newsletter
link.traderspro.com/dailytrade
link.traderspro.com/toolkit
Daily email newsletter
link.traderspro.com/dailytrade
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.